Current Studies

Bleeding Disorders
Hereditary Angioedema
Perioperative Bleeding
Therapeutic Proteins

Condition Additional Trial Information

Hereditary Angioedema Types I and II

A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

> Learn More

Von Willebrand Disease

Study of Voncento® in Subjects With Von Willebrand Disease

> Learn More

Hemophilia A

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

> Learn More

Hemophilia A With Inhibitors
Hemophilia B With Inhibitors

Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors

> Learn More

Congenital Coagulation Factor VII Deficiency

Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency

> Learn More

Page 1 of 3 Next | Last
LinkedIn Twitter Facebook Google+